Reading Room

Service Delivery Guidelines

 

Combined Oral Contraceptives (COCs)

TOC

Types

Monophasic: All 21 active pills contain the same amount of estrogen/progestin (E/P)
Biphasic: The 21 active pills contain 2 different E/P combinations (10/11)
Triphasic: The 21 active pills contain 3 different E/P combinations (6/5/10)

Mechanisms of Action

  • Suppress ovulation
  • Thicken cervical mucus, preventing sperm penetration
  • Change endometrium, making implantation less likely
  • Reduce sperm transport in upper genital tract (fallopian tubes)

Benefits

Contraceptive

  • Highly effective when taken daily (0.1–8 pregnancies per 100 women during the first year of use)
  • Effective immediately
  • Pelvic examination not required prior to use
  • Do not interfere with intercourse
  • Few side effects
  • Convenient and easy to use
  • Client can stop use
  • Can be provided by trained nonmedical staff

Noncontraceptive

  • Decrease menstrual flow (lighter, shorter periods)
  • Decrease menstrual cramps
  • May improve anemia
  • May lead to more regular menstrual cycles
  • Protect against ovarian and endometrial cancer
  • Decrease benign breast disease and ovarian cysts
  • Prevent ectopic pregnancy
  • Protect against some causes of PID

Limitations

  • User-dependent (require continued motivation and daily use)
  • Some nausea, dizziness, mild breast tenderness or headaches as well as spotting or light bleeding (usually disappear within 2 or 3 cycles)
  • Effectiveness may be lowered when certain drugs for epilepsy (phenytoin and barbiturates) or tuberculosis (rifampin) are taken
  • Can delay return to fertility
  • Forgetfulness increases failure
  • Serious side effects (e.g., heart attack, stroke, blood clots in lung or brain, liver tumors), though rare, are possible
  • Resupply must be available
  • Do not protect against STDs (e.g., HBV, HIV/AIDS)

Who Can Use COCs

  • Women of any reproductive age
  • Women of any parity including nulliparous women
  • Women who want highly effective protection against pregnancy
  • Women who are breastfeeding (6 months or more postpartum)
  • Women who are postpartum and not breastfeeding
  • Women who are postabortion
  • Women with anemia
  • Women with severe menstrual cramps
  • Women with irregular menstrual cycles
  • Women with histories of ectopic pregnancy

Conditions Requiring Precautions

CONDITION

RECOMMENDATION

High blood pressure Initiate and resupply after careful evaluation of condition. Women with BP <160/100 can use COCs.
Diabetes COCs can be used with uncomplicated diabetes or diabetes of less than 20 years duration.
Migraines If no focal neurological symptoms are associated with the headaches, COCs can be used.
Taking drugs for epilepsy or tuberculosis Provide higher estrogen (50 µg ethinyl estradiol) pills or help client choose another method.

Who Should Not Use COCs

  • Women who are pregnant (known or suspected)
  • Women who are breastfeeding and fewer than 6–8 weeks postpartum
  • Women with unexplained vaginal bleeding (until evaluated)
  • Women with active liver disease (viral hepatitis)
  • Women over age 35 who smoke
  • Women with a history of heart disease, stroke or high blood pressure (>180/110)
  • Women with a history of blood clotting problems or diabetes > 20 years
  • Women with breast cancer
  • Women with migraines and focal neurologic symptoms
  • Women who cannot remember to take a pill every day

When to Start

  • Anytime during the menstrual cycle when you can be reasonably sure the client is not pregnant
  • Days 1 to 7 of the menstrual cycle
  • Postpartum:
    • after 6 months if using LAM
    • after 3 weeks if not breastfeeding
  • Postabortion (immediately or within 7 days)

Management of Common Side Effects

SIDE EFFECT

MANAGEMENT

Amenorrhea
(absence of vaginal bleeding or spotting)
Clients using 21-day packs may forget to leave a pill-free week for menses. If pills are taken continuously, she may not have any periods. This is not harmful.

Check for pregnancy.

If not pregnant and client is taking COCs correctly, reassure. Explain that absent menses are most likely due to lack of buildup of uterine lining.

If not pregnant, no treatment is required except counseling and reassurance. If she continues low-dose estrogen COCs (30–35 µg EE), amenorrhea usually will persist. Advise client to return to clinic if amenorrhea continues to be a concern or switch to a high-dose estrogen (50 µg EE) pill if available and no conditions requiring precaution exist.

If intrauterine pregnancy is confirmed, counsel client regarding options. If pregnancy will be continued, stop use and assure her that the small dose of estrogen and progestin in the COCs will have no harmful effect on the fetus.

High blood pressure
(> 160/100)
If BP increases in a client with normal BP who is using COCs, follow closely. If any warning signs (severe headaches, chest pain, blurred vision) occur or BP > 160/100, the method should be stopped.

If COCs are stopped, help client choose another (nonestrogen) method. Tell her that high BP due to COCs usually goes away after 1–3 months. Take BP monthly to be sure it returns to normal. If after 3 months it has not, refer for further evaluation.

Nausea/Dizziness/ Vomiting Check for pregnancy. If pregnant, manage as above. If not, advise taking pill with evening meal or before bedtime. Reassure that symptoms usually decrease after first three cycles of use.
Vaginal bleeding/ Spotting Check for pregnancy or other gynecological conditions. Advise taking pills at the same time each day. Reassure that spotting/light menstrual bleeding is common during first 3 months of use and then decreases. If it persists, provide higher dose estrogen (50 µg EE) pills or help client choose another method.

Client Instructions

  • Take 1 pill each day, preferably at the same time of day.
  • Take the first pill on the first to the seventh day (first day is preferred) after the beginning of your menstrual period.
  • Some pill packs have 28 pills. Others have 21 pills. When the 28-day pack is empty, you should immediately start taking pills from a new pack. When the 21-day pack is empty, wait 1 week (7 days) and then begin taking pills from a new pack.
  • If you vomit within 30 minutes of taking a pill, take another pill or use a backup method if you have sex during the next 7 days.
  • If you forget to take 1 pill, take it as soon as you remember, even if it means taking 2 pills in 1 day.
  • If you forget to take 2 or more pills, you should take 2 pills every day until you are back on schedule. Use a backup method (e.g., condoms) or else do not have sex for 7 days.
  • If you miss 2 or more menstrual periods, you should come to the clinic to check to see if you are pregnant.

General Information

  • Some nausea, dizziness, mild breast tenderness and headaches as well as spotting or light bleeding are common during the menstrual cycle (usually disappear within 2 or 3 cycles).
  • Certain drugs (rifampin and most anti-epilepsy drugs) may reduce the effectiveness of COCs. For this reason, the client should tell her health care provider if she starts any new drugs.
  • COCs do not provide protection against STDs, including the AIDS virus. If either partner is at risk, they should use condoms as well as COCs.

WARNING SIGNS

FOR COMBINED ORAL CONTRACEPTIVE (COC) USERS

  • Severe chest pain or shortness of breath.
  • Severe headaches or blurred vision.
  • Severe leg pain.
  • Absence of any bleeding or spotting during pill-free week (21-day pack) or while taking 7 inactive pills (28-day pack) may be a sign of pregnancy.

Contact health care provider or clinic if you develop any of the above problems.

Who Can Provide

  • Physicians
  • Nurses, Midwives, Paramedics
  • Community-based Workers
  • Pharmacists

Where They Can Be Provided

  • Hospitals
  • Clinics
  • Health Posts
  • Community-based Distribution Programs
  • Pharmacies
  • Private Offices

TOC TOP


| Home | Family Planning | Maternal & Neonatal Health | Cervical CancerRelated Health Topics
Tools for Trainers
| Reading Room | Related Links | Search ReproLine | Website Tools

Quick Search 

Website design copyright © 1995-2003 by JHPIEGO Corporation. All rights reserved.

Last Updated: 09 Jul 2003

URL: http://www.reproline.jhu.edu/
Reproductive Health Online (ReproLine): a family planning and reproductive health training website